Table 1.
Variables | SAP (n = 56) | ACS (n = 144) | Control (n = 57) | P value |
---|---|---|---|---|
Age (years) | 61.3 ± 9.1 | 59.9 ± 12.5 | 45.6 ± 11.1 | 0.001 |
Sex (%) | ||||
Male (n = 123) | 42.8 | 54.9 | 35.1 | 0.02 |
Female (n = 134) | 57.2 | 45.1 | 64.9 | |
BMIa (Kg/m2) | 25 ± 3.7 | 24.9 ± 4.3 | 25.8 ± 4.3 | 0.4 |
Waist (cm) | 89.3 ± 13 | 91.3 ± 14.9 | 84.1 ± 15.9 | 0.005 |
Systolic blood pressure (mmHg) | 138.2 ± 20.8 | 135.9 ± 23.1 | 127.7 ± 9.3 | 0.01 |
Diastolic blood pressure (mmHg) | 81.1 ± 16.3 | 83.9 ± 41 | 76.9 ± 5.1 | 0.3 |
bLDL cholesterol (mg/dL) | 86.4 ± 27.4 | 102.6 ± 95.9 | 117.7 ± 42.1 | 0.09 |
cHDL cholesterol (mg/dL) | 44.1 ± 11.1 | 41.9 ± 10.6 | 46.7 ± 15.5 | 0.03 |
Total cholesterol (mg/dL) | 150.9 ± 36.4 | 157 ± 45.4 | 183.7 ± 40.2 | 0.003 |
Triglyceride (mg/dL) | 125.5 ± 59.2 | 127.8 ± 76.9 | 93.6 ± 33.7 | 0.003 |
dFBS (mg/dL) | 131 ± 51.1 | 129.9.9 ± 56.8 | 98.2 | <0.0001 |
Smoking (%) | 13 | 22.2 | 11.1 | 0.003 |
eLVEF (%) | 50 ± 15.5 | 46.4 ± 9.8 | — | 0.2 |
Gensini score | 32.4 ± 35.2 | 56.3 ± 47.8 | — | <0.0001 |
Medical treatment (%) | ||||
Aspirin | 71.2 | 49.4 | 0.0 | <0.0001 |
Beta-blocker | 27.3 | 24.5 | 0.0 | <0.0001 |
fACEI | 12.1 | 11.9 | 0.0 | 0.016 |
Statin | 50 | 33.3 | 0.0 | <0.0001 |
Nitrate | 50 | 26.9 | 0.0 | <0.0001 |
gCCB | 10.6 | 5.6 | 0.0 | <0.0001 |
hs-CRP (μg/mL) | 185 ± 144.7# | 262 ± 198.8*# | 147.6 ± 137.1 | 0.001 |
aBMI, body mass index; bLDL, low density lipoprotein; cHDL, high density lipoprotein; dFBS, fasting blood sugar; eLVEF, left ventricular ejection fraction; fACEI, angiotensin-converting enzyme inhibitor; gCCB, Calcium channel blocker.
*P < 0.05 versus control.
#P = 0.047.